Arca
Skip to content

PAH: Phenylalanine-4-hydroxylase

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Catalyzes the hydroxylation of L-phenylalanine to L-tyrosine. .

  • Drugs that act on it: 1
  • With a US drug page: 1
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
DrugUS approvalMechanismActionWarnings
SapropterinApprovedPhenylalanine-4-hydroxylase activatorActivator—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Hyperphenylalaninemia due to tetrahydrobiopterin deficiency
0.68
Hereditary disease
0.55
BH4-deficient hyperphenylalaninemia A
0.54
Pulmonary hypertension, primary, 1
0.46
Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis
0.42
Mild hyperphenylalaninemia
0.38
Malnutrition
0.37
Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria
0.37
Maternal phenylketonuria
0.37
Combined pituitary hormone deficiencies, genetic form
0.35

Drugs and mechanisms are from ChEMBL CHEMBL3076 (CC BY-SA 3.0). Gene name, function (UniProt P00439, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.